Scienture Holdings, Inc. SEC filings SCNX
Scienture Holdings, Inc. has 507 filings in SEC EDGAR's recent list, going back to Jun 15, 2007. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 27, 2025 | — |
| CORRESP | Letter to the SEC | Aug 26, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2025 | — |
| DRS | Filing | Aug 15, 2025 | — |
| EFFECT | Filing | Aug 8, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2025 | — |
| D/A | Filing | Aug 7, 2025 | — |
| CORRESP | Letter to the SEC | Aug 4, 2025 | — |
| CORRESP | Letter to the SEC | Aug 1, 2025 | — |
| D | Filing | Aug 1, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2025 | — |
| 1-A-W | Filing | Jul 15, 2025 | — |
| DRS | Filing | Jul 8, 2025 | — |
| EFFECT | Filing | Jun 17, 2025 | — |
| EFFECT | Filing | Apr 11, 2025 | — |
| CORRESP | Letter to the SEC | Apr 9, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2025 | — |
| DRS | Filing | Mar 18, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 12, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2025 | — |
| CORRESP | Letter to the SEC | Feb 6, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2025 | — |
| CORRESP | Letter to the SEC | Jan 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2025 | — |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Dec 30, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 20, 2024 | — |
| D | Filing | Dec 19, 2024 | — |
| 1-A/A | Filing | Nov 6, 2024 | — |
| 1-A | Filing | Sep 25, 2024 | — |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| NT 10-K | Filing | Apr 2, 2024 | Dec 31, 2023 |
| SEC STAFF ACTION | Filing | Feb 26, 2024 | — |
| NT 10-Q | Filing | Nov 15, 2023 | Sep 30, 2023 |
| PRER14A | Filing | Sep 25, 2023 | — |
| PRER14A | Filing | Sep 8, 2023 | — |
| NT 10-Q | Filing | Aug 14, 2023 | Jun 30, 2023 |
| 425 | Filing | Jul 14, 2023 | — |
| 425 | Filing | Jun 30, 2023 | — |
| EFFECT | Filing | Dec 2, 2022 | — |
| CORRESP | Letter to the SEC | Nov 30, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2022 | — |
| EFFECT | Filing | Aug 8, 2022 | — |
| CORRESP | Letter to the SEC | Aug 4, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2022 | — |
| EFFECT | Filing | Sep 3, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2020 | — |
| CORRESP | Letter to the SEC | Sep 1, 2020 | — |
| EFFECT | Filing | Feb 13, 2020 | — |
| CORRESP | Letter to the SEC | Feb 12, 2020 | — |
| CORRESP | Letter to the SEC | Feb 12, 2020 | — |
| CERT | Filing | Feb 11, 2020 | — |
| CORRESP | Letter to the SEC | Jan 27, 2020 | — |
| 8-A12B | Filing | Jan 27, 2020 | — |
| CORRESP | Letter to the SEC | Jan 24, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2019 | — |
| EFFECT | Filing | Nov 8, 2019 | — |
| DEFR14C | Filing | Oct 28, 2019 | — |
| DEFR14C | Filing | Oct 25, 2019 | — |
| D | Filing | Aug 8, 2019 | — |
| EFFECT | Filing | Jul 1, 2019 | — |
| CORRESP | Letter to the SEC | Jun 28, 2019 | — |
| CORRESP | Letter to the SEC | Jun 20, 2019 | — |
| UPLOAD | Letter from the SEC | May 28, 2019 | — |
| D | Filing | Nov 14, 2018 | — |
| D | Filing | Oct 25, 2018 | — |
| D | Filing | Jul 13, 2018 | — |
| D | Filing | Mar 21, 2017 | — |
| D | Filing | Jan 17, 2017 | — |
| D | Filing | Nov 3, 2015 | — |
| D | Filing | Oct 21, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2014 | — |
| CORRESP | Letter to the SEC | Sep 5, 2014 | — |
| 10-12G/A | Form 10/a3 | Sep 5, 2014 | — |
| D | Filing | Aug 27, 2014 | — |
| D | Filing | Aug 26, 2014 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2014 | — |
| CORRESP | Letter to the SEC | Aug 20, 2014 | — |
| 10-12G/A | Form 10-12g | Aug 20, 2014 | — |
| NT 10-Q | Form 12b-25 notice of late filing | Aug 14, 2014 | Jun 30, 2014 |
| UPLOAD | Letter from the SEC | Aug 6, 2014 | — |
| 10-12G/A | Form 10-12g/a | Jul 24, 2014 | — |
| CORRESP | Letter to the SEC | Jul 23, 2014 | — |
| CORRESP | Letter to the SEC | Jul 22, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2014 | — |
| 10-12G | Form 10 | Jun 11, 2014 | — |
| 15-15D | Form 15 | Jan 31, 2014 | — |
| NT 10-K | Xcellink nt 10k 123109 | Apr 1, 2010 | Dec 31, 2009 |
| NT 10-Q | Xcellink nt 10q 093009 | Nov 16, 2009 | Sep 30, 2009 |
| NT 10-Q | Xcellink - nt 10q 063009 | Aug 13, 2009 | Jun 30, 2009 |
| NT 10-Q | Xcellink nt 10q 033109 | May 15, 2009 | Mar 31, 2009 |
| UPLOAD | Letter from the SEC | Mar 30, 2009 | — |
| NT 10-K | Xcellink nt 10k 123108 | Mar 30, 2009 | Dec 31, 2008 |
| UPLOAD | Letter from the SEC | Mar 17, 2009 | — |
| DEFR14C | Bluebird defr 14c | Dec 10, 2008 | — |
| CORRESP | Letter to the SEC | Dec 2, 2008 | — |
| DEFR14C | Bluebird defr14c | Dec 1, 2008 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2008 | — |
| NT 10-Q | Bluebird exploration company form nt 10-q september 30, 2008 | Nov 14, 2008 | Sep 30, 2008 |
| 10KSB/A | Bluebird exploration company form 10-ksb/a (amendment no.1) december 31, 2007 | Mar 31, 2008 | Dec 31, 2007 |
| 10KSB | Bluebird exploration company december 31, 2007 10-ksb | Mar 28, 2008 | Dec 31, 2007 |
| 10QSB | Bluebird exploration company form 10-qsb september 30, 2007 | Nov 14, 2007 | Sep 30, 2007 |
| 10QSB | Bluebird exploration company form 10-qsb june 30, 2007 | Aug 13, 2007 | Jun 30, 2007 |
| 424A | Bluebird exploration company form 424 | Jul 10, 2007 | — |
| EFFECT | Filing | Jul 9, 2007 | — |
| SB-2 | Bluebird exploration company form sb-2 | Jun 15, 2007 | — |
Showing 110 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SCNX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Commack, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1382574
- Former names
- TRxADE HEALTH, INC (until Aug 28, 2024); TRXADE GROUP, INC. (until May 28, 2021); XCELLINK INTERNATIONAL INC. (until Jan 31, 2014); Bluebird Exploration Co. (until Dec 10, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.